Alnylam Pharmaceuticals
ALNY
#660
Rank
C$54.76 B
Marketcap
C$410.16
Share price
0.62%
Change (1 day)
-4.58%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company